Goodwill Impairment
Search documents
DoubleDown Interactive(DDI) - 2025 Q4 - Earnings Call Transcript
2026-02-11 23:02
DoubleDown Interactive Co. (NasdaqGS:DDI) Q4 2025 Earnings call February 11, 2026 05:00 PM ET Company ParticipantsEric Gregg - Founder and Sole OwnerIn Keuk Kim - CEOJoe Jaffoni - Investor Relations AdvisorJoseph Sigrist - CFOConference Call ParticipantsAaron Lee - Senior Research AnalystDavid Bain - AnalystEric Owen Handler - Managing Director and Senior Research AnalystJosh Nichols - Senior Research AnalystOperatorGood afternoon and welcome to DoubleDown Interactive's earnings conference call for the four ...
DoubleDown Interactive(DDI) - 2025 Q4 - Earnings Call Transcript
2026-02-11 23:02
DoubleDown Interactive Co. (NasdaqGS:DDI) Q4 2025 Earnings call February 11, 2026 05:00 PM ET Company ParticipantsEric Gregg - Founder and Sole OwnerIn Keuk Kim - CEOJoe Jaffoni - Investor Relations AdvisorJoseph Sigrist - CFOConference Call ParticipantsAaron Lee - Senior Research AnalystDavid Bain - AnalystEric Handler - Managing Director and Senior Research AnalystJosh Nichols - Senior Research AnalystOperatorGood afternoon and welcome to DoubleDown Interactive's Earnings Conference Call for the Fourth Qu ...
DoubleDown Interactive(DDI) - 2025 Q4 - Earnings Call Transcript
2026-02-11 23:00
DoubleDown Interactive Co. (NasdaqGS:DDI) Q4 2025 Earnings call February 11, 2026 05:00 PM ET Speaker7Good afternoon and welcome to DoubleDown Interactive's earnings conference call for the fourth quarter ended December 31st, 2025. My name is Sheri, and I will be your operator this afternoon. Prior to this call, DoubleDown issued its financial results for the fourth quarter of 2025 in a press release, a copy of which is available in the investor relations section of the company's website at www.doubledownin ...
Northfield Bancorp, Inc. Announces Strategic Transaction and Fourth Quarter and Year End 2025 Results
Globenewswire· 2026-02-02 12:41
NOTABLE ITEMS FOR THE QUARTER: NORTHFIELD BANCORP, INC. HAS AGREED TO MERGE WITH COLUMBIA FINANCIAL, INC. (NASDAQ: CLBK) SEE JOINT PRESS RELEASE FOR FURTHER DETAILS.CASH DIVIDEND OF $0.13 PER SHARE, PAYABLE FEBRUARY 25, 2026, TO STOCKHOLDERS OF RECORD AS OF FEBRUARY 12, 2026.$41.0 GOODWILL IMPAIRMENT CHARGE RECORDED RESULTING IN A NET LOSS FOR THE FOURTH QUARTER OF 2025 OF $27.4 MILLION, OR $0.69 PER SHARE, COMPARED TO NET INCOME OF $10.8 MILLION, OR $0.27 PER DILUTED SHARE, FOR THE TRAILING QUARTER, AND N ...
CVS Reports Big Loss On Devalued Oak Street Clinics But Aetna Costs Are Stable
Forbes· 2025-10-29 10:40
Core Insights - CVS Health reported a significant third-quarter loss of $4 billion, primarily due to the reduced value of its Oak Street Health primary care facilities [2][3] - Despite the loss, CVS raised its adjusted earnings per share guidance to a range of $6.55 to $6.65, up from $6.30 to $6.40, attributed to improved performance in its Aetna health insurance business [4] Financial Performance - The company experienced a net loss of $3.98 billion, or $3.13 per share, due to a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit, which includes Oak Street [6] - CVS's medical benefit ratio improved to 92.8% in the third quarter from 95.2% in the same period last year, indicating better management of health costs [5] - Revenues rose nearly 8% to a record $102.9 billion, driven by growth across all operating segments, with adjusted operating income increasing over 35% to $3.45 billion [10] Strategic Changes - CVS announced plans to close 16 Oak Street Health Centers, representing 7% of its senior-focused primary care locations, following challenges in the business's growth [7][8] - The company is reducing the number of new primary care clinics it will open in 2026 and beyond, reflecting updated financial projections and strategic changes in its health care delivery management team [9]
Centene posts $6.6B loss on massive value writedown
Yahoo Finance· 2025-10-29 07:59
Core Insights - Centene's results exceeded Wall Street expectations, indicating a "fairly positive" performance despite a mixed quarter overall [3] - The company reported a net loss of $6.6 billion in the third quarter, primarily due to a non-cash goodwill impairment charge of $6.7 billion [8] - Operationally, Centene is making progress on its turnaround, with a medical loss ratio of 92.7% in Q3, which is an increase from 89.2% year-over-year but lower than analysts' expectations [6] Financial Performance - Centene's earnings improved on an adjusted basis compared to the second quarter, although they were down year-over-year [3] - The company's stock hit a decade low in July following disappointing second quarter results, resulting in significant value loss [4] - The full-year earnings outlook was increased by executives following the quarterly results, indicating confidence in future performance [8] Market Context - The GOP's "One Big Beautiful Bill," which includes cuts to Medicaid and changes to the ACA, has negatively impacted Centene's goodwill and contributed to the impairment charge [5] - Medicaid remains a crucial segment for Centene, accounting for 45% of its nearly 28 million medical members and 52% of its $44.9 billion in premium and service revenue [7] - Elevated utilization in Medicaid continues to be a challenge for the company, but executives expressed satisfaction with managing medical costs [8]
Kentucky First Federal Bancorp Announces Fiscal Year Earnings
Globenewswire· 2025-09-19 21:29
Core Viewpoint - Kentucky First Federal Bancorp reported a significant turnaround in net income for the quarter and year ended June 30, 2025, achieving net income of $176,000 for the quarter and $181,000 for the year, compared to net losses in the previous year [1][14]. Financial Performance - The net income for the quarter increased by $1.3 million from a net loss of $1.1 million in the same quarter of 2024, while the annual net income improved by $1.9 million from a net loss of $1.7 million [1][14]. - The increase in net earnings for the quarter was primarily due to the absence of a goodwill impairment charge of $947,000 recorded in the previous year [2]. - Net interest income rose by $401,000 or 21.1% to $2.3 million, driven by a $545,000 or 12.3% increase in interest income, which outpaced a $144,000 or 5.7% rise in interest expense [3][4]. - Non-interest income surged by $59,000 or 113.5% to $111,000, largely due to increased net gains on sales of loans, reflecting a growing demand for fixed-rate secondary market loans [5]. Balance Sheet Highlights - As of June 30, 2025, total assets decreased by $3.8 million or 1.0% to $371.2 million, primarily due to a $5.8 million or 1.7% decrease in loans [8][13]. - Total liabilities decreased by $4.1 million or 1.3% to $322.8 million, with a notable reduction in FHLB advances by $26.2 million or 38.0% [8][13]. - Shareholders' equity increased by $372,000 or 0.8% to $48.4 million, attributed to a decrease in accumulated other comprehensive loss and net earnings for the period [9][13]. Earnings Metrics - The book value per share was reported at $5.98, reflecting a slight increase from $5.94 in the previous year [9][13]. - The average rate earned on interest-earning assets increased by 63 basis points to 5.25%, contributing to the rise in interest income [4].
Chord Energy Stock Dips 2.6% Since Q2 Earnings Miss Estimates
ZACKS· 2025-08-20 17:10
Core Viewpoint - Chord Energy Corporation (CHRD) shares have declined 2.6% following the release of second-quarter 2025 results, primarily due to weaker-than-expected earnings and a significant $539 million goodwill impairment overshadowing production growth and guidance [1][8]. Q2 Results - The company reported adjusted earnings of $1.79 per share, missing the Zacks Consensus Estimate of $1.88, and a significant decline from $4.69 in the same quarter last year [2][8]. - On a GAAP basis, the company recorded a net loss of $6.77 per share due to a $539 million non-cash goodwill impairment charge [2][8]. - Total quarterly revenues were $1,181 million, falling short of the Zacks Consensus Estimate of $1,295 million and down from $1,261 million in the prior year [2]. Operational Performance - Oil production averaged 156.7 thousand barrels per day (MBopd), an increase from 118.1 MBopd in the prior-year quarter [4]. - Total production reached 281.9 thousand barrels of oil equivalent per day (MBoepd), up from 207.2 MBoepd a year ago [4]. - Natural gas production was 425.9 million cubic feet per day (MMcf/D), up from 291.5 MMcf/D in the previous year [4]. - Natural gas liquids production totaled 54.1 MBbls/d, higher than 40.5 MBbls/d a year ago [4]. Realized Prices - The average realized crude oil price was $61.62 per barrel, down from $78.89 in the prior year [5]. - The average realized natural gas price increased to $1.10 per thousand cubic feet from 67 cents a year ago [5]. - Realized natural gas liquids price decreased to $5.80 per barrel from $9.99 in the same quarter last year [5]. Total Expenses - Lease operating expenses totaled $257 million, up from $176.6 million in the prior-year quarter [6]. - Gathering, processing, and transportation expenses increased to $74.1 million from $63.1 million in the comparable period of 2024 [6]. - Total operating expenses reached $1,583.3 million, up from $987.1 million in the previous year [6]. Balance Sheet & Liquidity - As of June 30, 2025, Chord Energy held cash and cash equivalents of $40.5 million, with long-term debt at $918.9 million [7]. - Liquidity stood at $1.83 billion, including credit facility availability [7]. - Capital expenditure amounted to $355.6 million, at the low end of the expected range [7]. Outlook for 2025 - Chord Energy expects oil production of 151.8-154.1 MBopd and total production of 272.5-278.3 MBoepd for 2025 [9]. - The company anticipates adjusted EBITDA of $2.4 billion and adjusted free cash flow of $850 million for the year [9]. - Capital expenditures for exploration and production are projected between $1.32 billion and $1.38 billion, with plans to complete 115-135 gross operated wells in Q3 2025 [9].
The J.M. Smucker Company (SJM) Faces Investor Scrutiny After Announcing The Second Hostess-Related Impairments In About 3 Months – Hagens Berman
GlobeNewswire News Room· 2025-07-16 21:54
Core Viewpoint - The J.M. Smucker Company experienced a significant decline in share price following disappointing Q4 2025 financial results, leading to an investigation into potential securities law violations related to its Hostess Brands acquisition [1][2][8]. Financial Performance - In Q4 2025, SJM reported a comparable net sales decrease of 14% in the Sweet Baked Snacks segment, alongside an $867 million impairment charge related to goodwill and an additional $113 million impairment of the Hostess Brand trademark [6][8]. - The company had previously reported a comparable net sales decrease of 8% in Q3 2025, with a $794 million impairment charge related to goodwill and a $208 million impairment charge to the Hostess Brand trademark [6][7]. Hostess Brands Acquisition - SJM acquired Hostess Brands for approximately $5.5 billion on November 7, 2023, with $2.4 billion recorded as goodwill in the Sweet Baked Snacks segment [3][4]. - The acquisition included various Hostess brands and manufacturing facilities across multiple states [4][5]. Investor Reactions and Investigations - Following the Q4 results, SJM's share price fell by $17.44, or 15%, resulting in a loss of about $1.8 billion in shareholder value [8]. - Hagens Berman has initiated an investigation into whether SJM may have misrepresented the benefits of the Hostess acquisition and whether it delayed the recognition of impairment charges [2][9].
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-06-25 01:00
Core Viewpoint - Maravai LifeSciences Holdings, Inc. is facing a class action lawsuit due to alleged breaches of fiduciary duties by its board of directors, following significant issues related to revenue recognition and internal controls [1][3]. Group 1: Financial Reporting Issues - On February 25, 2025, Maravai announced a postponement of its fiscal 2024 earnings release and the filing of its annual report on Form 10-K due to an error in revenue recognition, which resulted in approximately $3.9 million being incorrectly recorded [2]. - The company identified a material weakness in its internal controls over revenue recognition, necessitating additional time to assess a potential non-cash impairment charge related to goodwill from its acquisition of Alphazyme LLC [2]. - Following this announcement, Maravai's share price dropped by $0.87, or 21.70%, closing at $3.14 per share on February 25, 2025, amid unusually heavy trading volume [2]. Group 2: Allegations in Class Action Complaint - The class action complaint alleges that Maravai's executives made materially false and misleading statements and failed to disclose adverse facts about the company's operations and prospects [3]. - Specific allegations include the lack of adequate internal controls over financial reporting, inaccurate revenue recognition during fiscal 2024, and overstated goodwill [3]. - The complaint asserts that the positive statements made by the defendants regarding the company's business were materially misleading and lacked a reasonable basis due to these issues [3].